Boston Scientific Corp <BSX.N>: BTIG cuts target price to $60 from $65
BSX•Related News

BAT reaffirms full-year 2026 guidance, sees mid-teens New Category revenue growth
BTI•

Corcept Therapeutics Inc <CORT.O>: Canaccord Genuity Raises Target Price to $161 From $150
CORT•

Takeda FY26 Q1 operating profit rises 9.1% to JPY 201.4 billion
TAK•

Wingstop Inc <WING.O>: BTIG Cuts Target Price to $265 From $305
WING•

Anglo American first-half loss shrinks, raises dividend as Teck merger awaits approval
TECK•